BrightSpring Health Services, Inc. $BTSG Stock: Trek Financial LLC Reduces Stake

Trek Financial LLC lowered its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 67.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,013 shares of the company’s stock after selling 29,360 shares during the quarter. Trek Financial LLC’s holdings in BrightSpring Health Services were worth $795,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of BTSG. WESPAC Advisors LLC grew its holdings in shares of BrightSpring Health Services by 1.9% in the third quarter. WESPAC Advisors LLC now owns 11,942 shares of the company’s stock worth $678,000 after purchasing an additional 228 shares during the last quarter. Allworth Financial LP raised its holdings in BrightSpring Health Services by 179.3% during the 2nd quarter. Allworth Financial LP now owns 405 shares of the company’s stock valued at $28,000 after buying an additional 260 shares during the last quarter. State of Wyoming boosted its position in BrightSpring Health Services by 4.5% during the 1st quarter. State of Wyoming now owns 7,776 shares of the company’s stock valued at $331,000 after buying an additional 336 shares during the period. IFP Advisors Inc boosted its position in BrightSpring Health Services by 204.5% during the 2nd quarter. IFP Advisors Inc now owns 606 shares of the company’s stock valued at $42,000 after buying an additional 407 shares during the period. Finally, Arizona State Retirement System grew its holdings in BrightSpring Health Services by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 39,976 shares of the company’s stock worth $2,788,000 after acquiring an additional 423 shares during the last quarter.

BrightSpring Health Services News Summary

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Q3 results and outlook beat expectations. BrightSpring’s third-quarter earnings rose sharply, with pharmacy and home health growth contributing to revenue outperformance and margin expansion. The company raised its 2026 guidance, while specialty-drug launches and home health gains were cited as supports for organic growth into 2027. BrightSpring Q3 Earnings Beat on Specialty Growth, ’26 View Raised BTSG Q3 Earnings Call Highlights Raised Guidance and 2027 Growth
• Positive Sentiment: Analysts raised price targets and maintained bullish ratings. UBS lifted its target to $92 from $85 and kept a Buy rating; Leerink Partners also raised its target to $92, from $72, with an Outperform rating. Guggenheim and TD Cowen raised targets to $84, while Wells Fargo increased its target to $82. UBS Raises Price Target Leerink Partners Rating Guggenheim Rating TD Cowen Rating Wells Fargo Rating
• Positive Sentiment: Wall Street Zen upgraded BTSG to Strong Buy, adding to the favorable analyst sentiment. Wall Street Zen Upgrades BrightSpring to Strong-Buy
• Neutral Sentiment: A Zacks article highlighted BTSG as a potential long-term value stock based on its style-rating framework; this is an investing-style assessment rather than a new company announcement. Why BrightSpring Is a Top Value Stock for the Long-Term

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Morgan Stanley boosted their target price on BrightSpring Health Services from $71.00 to $80.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. KeyCorp reiterated an “overweight” rating on shares of BrightSpring Health Services in a report on Monday, August 3rd. Zacks Research downgraded shares of BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 2nd. Weiss Ratings upgraded shares of BrightSpring Health Services from a “hold (c+)” rating to a “buy (b)” rating in a report on Monday. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $90.00 target price on shares of BrightSpring Health Services in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $77.81.

BrightSpring Health Services Price Performance

Shares of NASDAQ BTSG opened at $69.84 on Wednesday. The company has a 50 day simple moving average of $60.29 and a two-hundred day simple moving average of $54.83. BrightSpring Health Services, Inc. has a fifty-two week low of $30.64 and a fifty-two week high of $73.75. The company has a market capitalization of $13.90 billion, a price-to-earnings ratio of 37.75, a P/E/G ratio of 0.80 and a beta of 1.77. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.22 and a current ratio of 1.62.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Friday, October 30th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.07. BrightSpring Health Services had a return on equity of 18.56% and a net margin of 2.69%. The company had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $3.88 billion. The business’s revenue was up 26.4% compared to the same quarter last year. Analysts expect that BrightSpring Health Services, Inc. will post 1.64 EPS for the current fiscal year.

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.